References

Changes in prevalence of health care–associated infections in U.S. hospitals

10.1056/nejmoa1801550 · 2018 · External reference

Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study

10.1371/journal.pmed.1002150 · 2016 · External reference

Infection in solid-organ transplant recipients

10.1056/nejmra064928 · 2007 · External reference

Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study

10.1093/cid/ciz1113 · 2020 · External reference

The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals

10.1093/oxfordjournals.aje.a113990 · 1985 · External reference

Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs

10.1086/657912 · 2011 · External reference

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

10.1086/595011 · 2009 · External reference

Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing

10.1093/cid/ciaa530 · 2020 · External reference

The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network

10.1017/ice.2021.362 · 2022 · External reference

National Healthcare Safety Network (NHSN) report, data summary for 2006 through 2007, issued November 2008

10.1016/j.ajic.2008.08.001 · 2008 · External reference

CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting

10.1016/j.ajic.2008.03.002 · 2008 · External reference

MALDI-TOF MS: a reliable tool in the real life of the clinical microbiology laboratory

10.3390/microorganisms12020322 · 2024 · External reference

Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

10.1128/jcm.00276-21 · 2022 · External reference

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

10.1111/j.1469-0691.2011.03570.x · 2012 · External reference

Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015-2017

10.1017/ice.2019.296 · 2020 · External reference

Clinical practice guidelines for antimicrobial prophylaxis in surgery

10.2146/ajhp120568 · 2013 · External reference

Aminoglycoside revival: review of a historically important class of antibiotics

2018 · External reference

Antimicrobial management of infections in solid-organ transplant recipients

2005 · External reference

Multidrug-resistant gram-negative bacterial infections in solid organ transplant recipients

2021 · External reference

Surveillance for control of antimicrobial resistance

10.1016/s1473-3099(17)30485-1 · 2018 · External reference

Carbapenem-resistant Acinetobacter baumannii bacteremia in liver transplant recipients

10.1016/j.transproceed.2018.01.043 · 2018 · External reference

The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections

10.1093/cid/ciab688 · 2022 · External reference

COVID-19 and the potential long-term impact on antimicrobial resistance

10.1093/jac/dkaa194 · 2020 · External reference

10.1093/cid/ciaa1478

10.1093/cid/ciaa1478 · 2021 · External reference

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

10.1016/s1473-3099(17)30753-3 · 2018 · External reference

Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): a multi-hospital cohort study

10.1093/cid/ciaa1239 · 2021 · External reference

The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace

10.1093/infdis/jiw282 · 2017 · External reference

Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation and impact on outcomes

2015 · External reference

Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis

10.1186/s12879-017-2383-z · 2017 · External reference

International consensus guidelines for the optimal use of the polymyxins

10.1002/phar.2209 · 2019 · External reference

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

10.1016/s0140-6736(21)02724-0 · 2022 · External reference